Sheldon J. Bleicher, M.D.; Martin G. Goldner, M.D., F.A.C.P.
This content is PDF only. Please click on the PDF icon to access.
During the past 12 months, five patients with organic hypoglycemia were treated with diazoxide (200 to 400 mg/day), either alone or in combination with chlorothiazide (500 mg/day), utilizing the thiazide hyperglycemia as a therapeutic modality. One patient suffered from glycogenosis, the four others from functioning islet cell tumors. In three of these four patients, the diagnosis had been confirmed surgically: two patients had been operated upon previously, and their recurrent symptoms were due to metastases; one patient underwent surgical removal of the tumor after the treatment period. Plasma glucose and insulin levels (immunoassayable insulin), the excretion of catecholamines, 17-ketosteroids and
Learn more about subscription options.
Register Now for a free account.
Bleicher SJ, Goldner MG. Management of Organic Hypoglycemia with Thiazide Derivatives.. Ann Intern Med. 1966;64:1172. doi: 10.7326/0003-4819-64-5-1172_1
Download citation file:
Published: Ann Intern Med. 1966;64(5):1172.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only